LOY BERTRAND

Average Profitability
3.36%
Insider Buys Quantity
11
Insider Buys Sum
$275,650.43
Insider Sells Quantity
53
Insider Sells Sum
$128.64M

Insider Activity of LOY BERTRAND

According to the SEC Form 4 filings, LOY BERTRAND, being in a position of

  1. President & CEO at Entegris, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 27044 shares for $3.8M,
    over all time since 2005-12-12, has bought 0 shares, and sold 2005016 shares for $128.64M.

The largest purchase of all time was on 2019-09-11 and amounted to 15590 shares of Harvard Bioscience, Inc. for $46,926.

The largest sale of all time was on 2021-04-05 and amounted to 300444 shares of Entegris, Inc. for $36.26M.

Biography of LOY BERTRAND

No biography is available at this moment.

2024-07-03SaleEntegris, Inc.
ENTG
President & CEO
27,044
0.0189%
$140.63$3.8M0%
2022-08-26PurchaseHarvard Bioscience, Inc.
HBIO
9,291
0.0231%
$3.41$31,682-5.78%
2022-08-24PurchaseHarvard Bioscience, Inc.
HBIO
8,244
0.0207%
$3.34$27,535-2.82%
2022-08-22PurchaseHarvard Bioscience, Inc.
HBIO
4,918
0.0118%
$3.16$15,541-2.21%
2022-08-18PurchaseHarvard Bioscience, Inc.
HBIO
1,151
0.0028%
$3.19$3,672-2.52%
2021-08-11SaleEntegris, Inc.
ENTG
President & CEO
23,710
0.0176%
$116.66$2.77M+4.71%
2021-08-10SaleEntegris, Inc.
ENTG
President & CEO
65,000
0.048%
$120.03$7.8M+1.45%
2021-08-09SaleEntegris, Inc.
ENTG
President & CEO
74,806
0.0551%
$121.49$9.09M0%
2021-08-04SaleEntegris, Inc.
ENTG
President & CEO
56,178
0.0418%
$125.44$7.05M-1.96%
2021-04-14SaleEntegris, Inc.
ENTG
President & CEO
100,000
0.0741%
$118.43$11.84M+4.08%
2021-04-13SaleEntegris, Inc.
ENTG
President & CEO
100,000
0.0736%
$117.96$11.8M+3.81%
2021-04-12SaleEntegris, Inc.
ENTG
President & CEO
100,000
0.0736%
$119.36$11.94M+2.6%
2021-04-05SaleEntegris, Inc.
ENTG
President & CEO
300,444
0.2222%
$120.69$36.26M+2%
2020-07-31SaleEntegris, Inc.
ENTG
President & CEO
118,520
0.0877%
$71.80$8.51M+41.22%
2020-07-27SaleEntegris, Inc.
ENTG
President & CEO
75,943
0.0564%
$69.64$5.29M+43.39%
2019-11-13PurchaseHarvard Bioscience, Inc.
HBIO
director
6,100
0.0166%
$2.52$15,372+22.45%
2019-11-12PurchaseHarvard Bioscience, Inc.
HBIO
director
10,579
0.028%
$2.51$26,553+19.52%
2019-11-11PurchaseHarvard Bioscience, Inc.
HBIO
director
12,855
0.0341%
$2.59$33,294+16.28%
2019-11-08PurchaseHarvard Bioscience, Inc.
HBIO
director
6,616
0.0169%
$2.64$17,466+9.12%
2019-09-13PurchaseHarvard Bioscience, Inc.
HBIO
director
7,372
0.0191%
$3.11$22,927-7.28%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.